WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Interview: IMF official warns lack of vaccination in lowJapan's campaign to revive domestic tourism sparks controversyKey Takeaways from Xi's State Visit to VietnamTrend of 'rise of the East and decline of the West' inevitable: economistDesert locusts seen in Sanaa, YemenPeople buy sheep at livestock market ahead of Eid alStoried apparel retailer Brooks Brothers files for bankruptcy amid pandemicOrange harvest in central Gaza StripBeijing to welcome 50 giant pandas to new research baseFoldable phones surge in popularity amid stagnant market
2.7546s , 6496.875 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Cultural Compass news portal